Company: IDev Technologies
Based: Webster, Texas
Investors: Piper Jaffray & Co.'s Merchant Banking Fund, PTV Sciences, Bay City Capital, RiverVest Venture Partners and Heron Capital
Scoop: IDev Technologies completed a $46 million Series D round of financing last October. The proceeds from the financing were to be used to fund SUPERB, the IDE superficial femoral artery clinical trial for the company's self-expanding SUPERA stent. The company also planned to use the proceeds for new clinical trials in support of other peripheral artery indications, as well as the development of new interventional products and sales and marketing initiatives to support continued revenue growth. Shortly after the close of the round, the company got the FDA's OK to market its Supera Veritas transhepatic biliary system.